# Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America

> **NCT01331655** · PHASE3 · WITHDRAWN · sponsor: **Bayer**

## Conditions studied

- Contraception

## Interventions

- **DRUG:** EE20/DRSP (BAY86-5300)
- **DRUG:** EE20/DRSP/L-5-MTHF (BAY98-7071)
- **DRUG:** EE20/DRSP/L-5-MTHF (BAY98-7071) + L-5-MTHF (BAY86-7660)

## Key facts

- **NCT ID:** NCT01331655
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-04
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331655, "Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01331655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*